LifeStance Health (LFST) Depreciation & Amortization (CF) (2020 - 2026)

LifeStance Health (LFST) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $13.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 3.18% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $54.3 million (down 12.6% YoY), while the FY2025 annual figure was $54.8 million, down 22.83% from the prior year.
• Depreciation & Amortization (CF) retreated to $13.3 million in Q1 2026 per LFST's latest filing, from $13.4 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $22.6 million in Q1 2024 and bottomed at $13.3 million in Q1 2026.
• Historically, Depreciation & Amortization (CF) has averaged $17.0 million across 5 years, with a median of $16.7 million in 2022.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 31.07% — and 2025, when it plunged 39.04%.
• LifeStance Health's Depreciation & Amortization (CF) stood at $18.9 million in 2022, then gained by 17.63% to $22.2 million in 2023, then slumped by 33.96% to $14.7 million in 2024, then declined by 8.43% to $13.4 million in 2025, then decreased by 0.86% to $13.3 million in 2026.
• Business Quant data shows LFST's Depreciation & Amortization (CF) at $13.3 million in Q1 2026, $13.4 million in Q4 2025, and $13.6 million in Q3 2025.